NCT00001696View on ClinicalTrials.gov

A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

April 30, 1998

Study Completion Date

March 31, 2001

Conditions

Cancer

Interventions

DRUG

Genistein

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00001696 - A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor | Biotech Hunter | Biotech Hunter